| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | BCL2L14 |
| Uniprot No | Q9BZR8 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-327aa |
| 氨基酸序列 | MCSTSGCDLEEIPLDDDDLNTIEFKILAYYTRHHVFKSTPALFSPKLLRTRSLSQRGLGNCSANESWTEVSWPCRNSQSSEKAINLGKKKSSWKAFFGVVEKEDSQSTPAKVSAQGQRTLEYQDSHSQQWSRCLSNVEQCLEHEAVDPKVISIANRVAEIVYSWPPPQATQAGGFKSKEIFVTEGLSFQLQGHVPVASSSKKDEEEQILAKIVELLKYSGDQLERKLKKDKALMGHFQDGLSYSVFKTITDQVLMGVDPRGESEVKAQGFKAALVIDVTAKLTAIDNHPMNRVLGFGTKYLKENFSPWIQQHGGWEKILGISHEEVD |
| 预测分子量 | 63.6 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于BCL2L14重组蛋白的3篇参考文献及其摘要概括：
1. **文献名称**：*"BCL2L14 promotes apoptosis by inducing crosstalk between the mitochondrial and death receptor pathways"*
**作者**：Wang, X. et al. (2016)
**摘要**：该研究通过表达重组BCL2L14蛋白，揭示其通过激活线粒体途径和死亡受体途径的交互作用促进细胞凋亡，尤其在肿瘤细胞中调控caspase-8和BAX的活化。
2. **文献名称**：*"Recombinant BCL2L14 protein induces autophagic cell death via disrupting Beclin1-BCL2 complexes"*
**作者**：Li, J. et al. (2018)
**摘要**：作者利用重组BCL2L14蛋白证明其通过竞争性结合BCL2.释放Beclin1以激活自噬性细胞死亡，为BCL2L14在自噬相关疾病中的作用提供机制依据。
3. **文献名称**：*"Structural and functional characterization of the pro-apoptotic protein BCL2L14"*
**作者**：Chen, Y. et al. (2020)
**摘要**：该研究通过重组BCL2L14蛋白的体外实验解析其三维结构，发现其BH3结构域对促凋亡功能至关重要，并验证其与抗凋亡蛋白MCL1的相互作用。
(注：以上文献信息为示例性概括，实际文献需通过学术数据库检索确认。)
**Background of BCL2L14 Recombinant Protein**
BCL2L14 (B-cell lymphoma 2-like 14), also known as BCL-G, is a member of the BCL-2 protein family, which regulates apoptosis (programmed cell death) by modulating mitochondrial outer membrane permeabilization. Unlike some anti-apoptotic BCL-2 family members (e.g., BCL-2. BCL-XL), BCL2L14 is classified as a pro-apoptotic protein. It contains conserved BCL-2 homology (BH) domains critical for interactions with other apoptotic regulators. However, its precise mechanistic role remains less characterized compared to well-studied relatives like BAX or BAK.
BCL2L14 is expressed in various tissues, with studies suggesting involvement in cellular stress responses, tissue homeostasis, and cancer progression. Its overexpression can promote apoptosis under certain conditions, potentially through BH3 domain-mediated activation of pro-death pathways or inhibition of anti-apoptotic proteins. Notably, BCL2L14 may exhibit context-dependent functions, as some reports indicate dual roles in apoptosis and autophagy regulation.
Recombinant BCL2L14 protein is typically produced using bacterial (e.g., *E. coli*) or mammalian expression systems to enable functional studies. Purification often involves affinity tags (e.g., His-tag) and chromatography techniques. This recombinant tool facilitates investigations into its structure, interactions (e.g., with BCL-2 family members or caspases), and role in diseases like cancer, where dysregulated apoptosis is a hallmark. Emerging research also explores its potential as a therapeutic target or biomarker. Despite progress, further work is needed to clarify its regulatory mechanisms and physiological relevance in health and disease.
×
